Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|May 28, 2005
Absence of CCR6 inhibits CD4+ regulatory T-cell development and M-cell formation inside Peyer's patchesAndreas Lügering, Martin Floer, Sabine Westphal, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 12, 2011
The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's diseaseJan Däbritz, Frauke Friedrichs, Toni Weinhage, et al.
Annals of Hepatology|June 17, 2011
Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipientRalf Bahde, Jens P Hölzen, Heiner H Wolters, et al.
The American Journal of Pathology|July 12, 2011
The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier functionDominik Bettenworth, Marion Buyse, Markus Böhm, et al.
Scientific Reports|September 3, 2024
Induction and maintenance of mucosal healing in Crohn's disease with ustekinumab in clinical practice across all care levels in Germany (MUCUS)Daniel C Baumgart, Andreas Stallmach, Philip Grunert, et al.
British Journal of Pharmacology|July 19, 2016
The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltrationTobias M Nowacki, Alan T Remaley, Dominik Bettenworth, et al.
International Journal of Oncology|December 6, 2005
Expression of vascular cell adhesion molecule-1 (CD 106) in normal and neoplastic human esophageal squamous epitheliumJan Heidemann, Christian Maaser, Andreas Lügering, et al.
The American Journal of Pathology|February 9, 2008
Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: evidence of defective M-cell formation in vivoSabine Westphal, Andreas Lügering, Julia von Wedel, et al.
Journal of Crohn'S & Colitis|March 28, 2025
Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC studyBernd Bokemeyer, Sandra Plachta-Danielzik, Elena Gilman, et al.
Inflammatory Bowel Diseases|July 28, 2018
Syndecan-4 Modulates Epithelial Gut Barrier Function and Epithelial Regeneration in Experimental ColitisMareike Fröhling, Phil Tepasse, Johanna Intemann, et al.
Pageof 4